Everything you need to know
about the Global Bioenergies group
Everything you need to know
about the Isobutene process
Everything you need to know about
Global Bioenergies’ corporate governance
Click here to go to the website
for Investors and Shareholders
Global Bioenergies was founded in 2008 with a unique goal – to develop a process converting renewable resources (sugar, crops, agricultural and forestry waste) into isobutene, one of the main petroleum derivatives.
Because isobutene, one of the major building blocks of the petrochemicals industry, represents a market worth $25 billion and may one day address an additional market worth $400 billion.
Because micro-organisms do not naturally produce isobutene. And it’s easy to understand why.
To begin with, Global Bioenergies successfully set up a laboratory-scale prototype to provide proof of concept for its technology.
Secondly, after its IPO on the Alternext market, the Company refined its process on a laboratory scale.
Stage 3, which began when €23 million in funds were raised in mid-2013, was devoted to industrialization.
The fourth stage – launching the technology in the marketplace – is only just beginning. The plan to set up the first full-scale plant in France is already starting to come together.
Joint-Venture avec Cristal Union
First renewable gasoline sample delivered to Audi
First isobutene delivery to Arkema
Prêt de 4,4M€ d’un consortium de banque française, démarrage de la construction du démonstrateur en Allemagne
Successful completion of the first isobutene test at its Pomacle-Bazancourt industrial pilot
Start-up of the industrial pilot
Partnership with Audi to develop a drop-in biofuel
€5.2 million in funding under the Investissements d’Avenir program
Partenariat avec ARKEMA et le CNRS
Synthos establishes a stake for €2.7 million
Laboratory prototype
